Sun Pharma's stock closed at ₹1721.1 on January 2, 2026, with a market capitalization of ₹412,949.54 crore. The trading volume was 877,515 shares. Key financial indicators include a price-to-earnings ratio of 39.52 and an earnings per share of 43.55. The liveblog provided real-time updates and analysis, including fundamental and technical indicators, to inform investment decisions.